The study also found that higher serum TK1 concentrations at diagnosis were associated with an increased risk of death from prostate cancer, suggesting that serum TK1 levels could serve as a prognostic marker for prostate cancer patients4. This evidence concerns the gene TK1 and Familial prostate cancer.